Caliper Gets $11M for Xenogen Biosciences Sale | GenomeWeb

This article has been updated to include comments from a conference call.

NEW YORK (GenomeWeb News) – Caliper Life Sciences today said that it has sold its Xenogen Biosciences subsidiary to Taconic Farms for approximately $11 million.

Xenogen Biosciences provides in vivo pre-clinical CRO services and became part of Caliper through the acquisition of Xenogen Corp. in 2006.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.

An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.

The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.

For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.